Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose phase 1 study of KHK7580 in peritoneal dialysis patients with secondary hyperparathyroidism
jRCT2080222486Phase 1
- Sponsor
- Kyowa Kirin
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of ASP7991 in secondary hyperparathyroidism (SHPT) and chronic kidney disease (CKD), sponsored by Kyowa Kirin.
02
Drugs
ASP7991
03
Conditions
secondary hyperparathyroidism (SHPT)chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT2080222486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222486.